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Novel Drug Carriers: From Grafted Polymers to Cross-linked Vesicles† 
Jiangtao Xu, a Qiang Fu,a Jing M. Ren, a Gary Bryant b and Greg G. Qiao*a 
 
A simple and straightforward method of self-assembling grafted copolymers was developed to 
fabricate cross-linked polymer vesicles, which could conjugate anticancer drug cis-platinum and 
possess the capability of a high drug loading content, and a steady release rate. 
Synthetic polymer nanoparticles have long been sought as nano-carriers for drug delivery because they 
are amenable to precise morphological control and surface modification.1 Polymer vesicles are 
particularly attractive materials since their sizes, structures and functions can be readily tailored to suit 
many desirable applications in nanomedicine through careful selection of the polymer structures and 
properties.2 
 Of particular interest is the preparation of polymer vesicles in aqueous solution from different 
topological copolymers. The intrinsic macromolecular parameters including block copolymer 
architecture, hydrophobic interactions, and the  hydrophobic/hydrophilic balance, determine the nature 
of the morphologies of these block copolymers. Among them, block copolymer architecture has been 
extensively investigated for simple linear-linear (coil-coil, coil-rod, rod-rod, and supplementary 
interaction),3 and linear-branched (or dendrimer) structures.4 
 Herein, we report on the construction of robust polymer vesicles self-assembled from linear-brush 
polyoxanorbornene-based diblock copolymers by pH triggering. The double bonds formed in the 
polymer backbone provide the capability of cross-linking vesicular structure by thiol-ene “click” 
chemistry with a biodegradable linker. These cross-linked polymer vesicles can be utilized to conjugate 
anticancer drug cis-platinum with high loading content. To the best of our knowledge, this is the first 
example of a morphological investigation of grafted copolymers self-assembled in aqueous condition. 
 We designed linear-brush diblock copolymers, 3 in Scheme 1, via ring-opening metathesis 
polymerization (ROMP) utilizing two monomers, oxanorbornenyl anhydride (ONBAn) and ω-
oxanorbornenyl poly(ethylene glycol) (Mn=2000) macromonomer (ONB-PEG2K, 2, ESI). The 
anhydrides in the linear block would be modified to di-acid functionalities through hydrolysis, which 
would be responsive towards pH in aqueous solution and also provide binding sites for cis-platinum 
drug conjugation. The oxygen in the oxanorbornene monomer was expected to be more hydrophilic and 
hence increase the probability of biocompatibility for the resulting copolymers.5 PEG was employed to 
construct the brush block due to its prestige as the most important and widely used biocompatible 
polymer in pharmaceutical and biomedical applications. Brush and hyperbranched polymers generally 
display longer in vivo retention times compared to their linear polymer analogues.6 
 ROMP initiated by ruthenium Grubbs’ catalyst is a powerful tool to make well-defined polymers with 
low polydispersity, high conversion, and precisely controlled degrees of polymerization by easily 
adjusting the monomer to catalyst ratio. Particularly, it has been proved to be very useful to make brush 
polymers.7 The linear-brush block copolymers, P(ONBAn)m-b-P(ONB-PEG2K)n, with two different 
block ratios were synthesized via sequential addition of (macro)monomers of ONBAn and ONB-
PEG2K in the presence of pyridine modified 2nd generation Grubbs’ catalyst. It gave light grey powder, 
3: Mn (GPC) = 14,500, Mw/Mn = 1.14 for P(ONBAn)25-b-P(ONB-PEG2K)5 and Mn (GPC) = 19,400, 
Mw/Mn = 1.16 for P(ONBAn)50-b-P(ONB-PEG2K)5. 
 Hydrolysis was carried out in 0.1 M NaOH solution for 1 hr. After dialysis against deionized water, 
the polymer solutions were freeze-dried to give viscous products, 4: diblock copolymers P(ONB-
diacid)25-b-P(ONB-PEG2K)5 (denoted as DP25) and P(ONB-diacid)50-b-P(ONB-PEG2K)5 (denoted as 
DP50). 
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The self-assembly proceeded via dissolution of the diblock copolymer 4 at a concentration of 3 mg/mL. 
The pH value of the solution was adjusted to be ~12 (measured by pH meter) by adding 2M NaOH 
solution. Subsequently, 2 M HCl was added slowly into the solution to tune pH values. Dynamic light 
scattering (DLS) studies of these solutions with varied pH value (Fig. 1A and Fig. S5) for DP25 were 
performed. Fig. 1A showed that Dh did not change as the pH decreased from 12 to 5. It was around 5 nm, 
which means the polymers were dissolved molecularly. However, the size abruptly increased from 5 nm 
to 150 nm as pH decreased from 5 to 4, which indicated the formation of micellar aggregates. 
 
 
Scheme 1 The chemistry of constructing cross-linked polymer vesicles and their drug conjugation with 
cis-platinum. 
 
 
 
 
Fig. 1 Hydrodynamic particle sizes (Dh) of self-assembled DP25 (A) at varied pH before cross-linking, 
(B) at pH 4 before and after cross-linking, and (C) at different pH after cross-linking. 
 It is well known that poly(carboxylic acid) chains undergo dramatic conformational changes, from an 
extended rod-like chain to a hypercoil as the pH value decreases. Such a change occurs gradually over a 
large pH range. Thus, the sharp transition at pH 4~5 in Fig. 1 cannot only be attributed to the simple 
conformational variation of poly(carboxylic acid) chains. In fact, the acid in poly(carboxylic acid) 
acting as a proton-donating groups can form interpolymer complexes (IPC) by H-bonding with proton-
accepting ether groups in some polymers like PEG and poly(vinyl ether) at low pH. This phenomenon 
had been extensively studied since it was first reported in 1959.8 Therefore, the sharp transition at pH 4 
~ 5 in our work could be attributed to IPC between poly(carboxylic acid) and polyoxanorbornene ether 
backbone or PEG brush (Scheme S2). However, accompanying the hydrophobic intermolecular 
association of poly(carboxylic acid)s, it was proposed that the complexation between poly(carboxylic 
acid) and polyoxanorbornene ether backbone would be more favorable than that between 
poly(carboxylic acid) and PEG brush. 
 Taking into account the semi-rigidity of the polyoxanorbornene backbones, the molecular packing and 
IPC will tend to form bilayer structure, i.e. vesicles, at pH 4. Obviously, the particle size (Dh =150 nm) 
was far higher than the maximum theoretical value for spherical micelles (~74 nm for the fully extended 
chain length of the constituent blocks, roughly estimated by summation of the average backbone length 
unit of C-C-O at 0.23 nm). Furthermore, light scattering (LS), transmission electron microscopy (TEM) 
and atomic force microscopy (AFM) measurements provided convincing evidence that the structures are 
vesicles. However, cross-linking of the vesicles can provide a permanent vesicle for morphology 
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observed.?? 
 Due to the olefin functionalities on polyoxanorbornene backbone, which can be applied for the thiol-
ene click reaction9 with high tolerance in many different conditions and solvents,10 these vesicles were 
cross-linked by tetra-functional thiol cross-linker, pentaerythritol tetrakis(3-mercaptopropionate) 
(PETMP), in the presence of photo initiator, 2,2-dimethoxy-2-phenyl acetophenone (DMPA). It is 
worthy to note that β-thioester bonds in PETMP were used as a labile linker because it can be easily 
hydrolyzed by esterase, which is abundant in cells.11 Therefore, the resultant cross-linked polymer 
vesicles are likely to be  biodegradable if used as drug carriers. Although the grafted polymer segments 
cannot degrade, they can be cleared from blood circulation since their molecular weights are far below 
renal clearance threshold (40K for linear PEG).12 
 The cross-linker and photo initiator were encapsulated into the hydrophobic part of polyacid 
aggregates due to their hydrophobic properties. The thiol-ene “click” reaction was performed under 365 
nm UV light overnight. DLS measurements (Fig. 1B) confirmed that the particle size did not change 
(~150 nm) before and after cross-linking. 
 DLS studies (Fig. 1C) showed the particles had expanded after cross-linking and dialysis, around 150 
nm at pH lower than 4 to 18 nm at pH 11. This size increase was due to increased swelling of the 
particles when pH was increased. A control experiment was performed under identical reaction 
condition without PETMP; upon changing of pH to 7, no large-sized nanoparticles were observed by 
DLS, which indicates the disassembly of uncross-linked polymer particles. The other grafted copolymer 
DP50 gave similar results in DLS (Fig. S6, ESI) with particle size of ~190 nm at low pH and ~210 nm 
at high pH after cross-linking. 
 The combination of DLS and SLS measurement can provide detailed information of vesicles, 
including vesicle size, shell thickness and size distribution.13 Theoretical analysis of SLS measurements 
of the cross-linked polymer vesicles was conducted using established mathematical models.14 For the 
cross-linked polymer vesicle from diblock copolymer P(ONB-diacid)25-b-P(ONB-PEG2K)5 (denoted as 
CPV25), the best fit was achieved using a hollow sphere (vesicle) model (Equation S1, red line in Fig. 
S7) with a log-normal distribution of particle sizes. This model is in reasonable agreement with the SLS 
data, yielding a diameter of 132 nm, which matches well with the DLS data. Moreover, the shell 
thickness was calculated to be 27 nm. By comparison, no good fit could be obtained using the solid 
sphere (micelle) model (Equation S3, green line in Fig S7). The other sample of cross-linked polymer 
vesicle from diblock copolymer P(ONB-diacid)50-b-P(ONB-PEG2K)5 (denoted as CPV50) was fitted 
(Fig. S8) using the vesicle model with a Schulz distribution, yielding a diameter of 188 nm and shell 
thickness of 37 nm. Again no good fit could be obtained using a micelle model. 
 
Fig. 2 TEM images with negative staining (A) and cryo-TEM images with positive staining (B) for 
CPV25. 
 Analysis of a dried sample of the CPV25 by TEM negatively stained with uranyl acetate showed 
polydisperse spherical micelles with average ~155 nm particle size (Fig. 2A and Fig. S10), which agrees 
with LS results. The high polydispersity originates from the formation mechanism of polymer vesicles. 
Generally, they are formed from a block copolymer to an assembled single bilayer membrane, with a 
hydrophobic middle layer and hydrophilic surfaces, and the resulting membrane folds over and 
rearranges by connecting its edges to enclose a space. No mechanism selects for the overall size, so the 
size distribution tends to be very polydisperse. It also induced the morphologies of fully enclosed and 
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partially enclosed vesicles, which can be seen in TEM and AFM measurements. 
 Upon positive staining with loaded drug cis-platinum (selective staining for the di-acid block), 
definable bilayer structure with 25 nm shell thickness were observed from cryo-TEM (Fig. 2B and Fig. 
S11), clearly indicating vesicular morphology. The shell thickness was a little smaller than that from LS 
results (27 nm) due to unstained thin PEG layers. Additionally, it indicated that some bowl-shaped and 
partially enclosed vesicles (Fig. 2B bottom and Fig. S11C, ESI) were observed. 
 AFM measurement (Fig. S12) further confirmed the results by a diameter to height ratio of 7.5 to 1, a 
hollow property of the nanoparticles. The height showed doubled shell thickness of the polymer vesicles. 
With a single thickness of around 22 nm, which is slightly smaller than 25 nm from cryo-TEM 
measurements, as the AFM sample in the dried state.  
 These novel cross-linked polymer vesicles are ideal nano-carriers for anti-cancer drug cis-platinum, 
because the diacid bilayer shell has the tendency to bind cis-platinum, forming metal complexes which 
can release drugs by hydrolytically cleaving carboxylic groups. Moreover, dicarboxylate-platinum 
complexes with a 6~8 membered ring structure can normally provide higher stability and loading 
contents to their conjugates.15 In this work, the di-acid structures have the potential to form stable 
platinum complex with 7-membered rings. 
 In a specific experiment, the basic solution (pH = 12) of CPV25 was mixed with freshly prepared cis-
diaminediaqua platinum(II) complex solution from cis-dichlorodiamine-platinum(II) (CDDP) at given 
carboxylate/cis-platinum molar ratios (2/1), resulting in light brown solution in an extremely short time 
(< 5 min). It presented the rapid formation of polymer-platinum conjugates as well as high drug 
conjugation efficiency determined by TGA to be 88.4% (see Fig. S13 and its calculation in ESI), which 
suggested that most carboxylate functional groups were involved in complex formation as 7-membered 
ring complexes. We believed that this stable complex promoted effective drug conjugation. However, 
no morphology for this complex structure can be determined without further investigation.. However, 
this is not a concern when good drug loading and release profiles are obtained. The drug loading content 
was calculated to be 18.9% based on the conjugation efficiency, which is much higher than previously 
reported (generally less than 10% 16). 
 
Fig. 3 Release profile of CDDP from CPV25 in saline solution (0.9% NaCl, pH 7.4). The line was fitted 
according to equation % CDDP released = A exp (-t/τ) + y0. 
 The in vitro release of the CDDP from a polymer vesicle solution was performed by a dialysis 
method.15 As shown in Fig. 3, the drug release profile followed a steady release rate, which meets the 
criterion that drug levels in the body remain constant while the drug is being administered. The release 
kinetics can be described by a simple first-order mathematical model, although the release behaviour is 
complicated, combining diffusion (out of polymer vesicles) and chemically controlled processes (de-
complexation).17 It gave similar results to those reported by Huynh et al,15 with release constant, τ, 47.84 
hours. 
 In summary, this work presents a straightforward method to prepare biodegradable cross-linked 
polymer vesicles, which are capable of conjugating cis-platinum drug with a high loading content and 
steady release rate. The polymer vesicles were fabricated by self-assembly of linear-brush grafted 
copolymer forming interpolymer complexes by H-bonding in the presence of pH triggering.  
 The authors wish to acknowledge the University of Melbourne (Early Career Researcher Grant 2012) 
for financial support and valuable advices and suggestions from Dr. Adrain Sulistio. 
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Experimental Section 
Materials: poly(ethylene glycol) monoether (Mn ~ 2000 Da), N-propargylamine (98%), copper(I) 
bromide (CuBr, 98%), N,N,N’,N’’,N’’-pentamethyldiethylenetriamine (PMDETA, 99%), Grubbs 
catalyst (2nd Generation) (H2IMes)(PCy3)(Cl)2RuCHPh, cis-dichlorodiaminoplatinum (II) (CDDP, 
99.9%), pentaerythritol tetrakis(3-mercaptopropionate) (PETMP, >95%), 2,2-dimethoxy-2-phenyl 
acetophenone (DMPA, 99%) and anhydrous pyridine (99.8%) were all purchased from Aldrich and used 
as received. N,N-dimethylformamide (99.8%, Merck), n-hexane (AR, Chem-Supply), diethyl ether (AR, 
Chem-Supply), sodium azide (NaN3, 99%, Chem-Supply), 1,8,9-anthrancenetriol (DIT, puriss, Fluka) 
and trans-2-[3-(4-tert.-butylphenyl)-2-methyl-2-propenylidene]-malononitrile (DCTB, puriss, Fluka) 
were also used as received. Exo-7-oxabicyclo[2.2.1] hept-5-ene-2,3-dicarboxylic anhydride (oxa-
norbornenyl anhydride, ONBAn)1, azido-terminated poly(ethylene glycol) monomethyl ether with 
molecular weight 2000 Da (PEG2K-N3),2,3 and pyridine modified Grubbs Catalyst (2nd Generation) 
(H2IMes)(pyr)2(Cl)2RuCHPh 4 were synthesized according to literature procedures.  
Instrumentation. Gel permeation chromatography (GPC) (THF as eluent) was performed on a 
Shimadzu liquid chromatography system fitted with a Wyatt DAWN EOS multi-angle laser light 
scattering (MALLS) detector (690 nm, 30 mW) and a Wyatt OPTILAB DSP interferometric 
refractometer (690 nm), using three Phenomenex Phenogel columns (500, 104, and 106 Å porosity; 5 
µm bead size) operated at 1 mL/min with column temperature set at 40 oC. Astra software (Wyatt 
Technology Corp.) was used to process the data to determine the molecular weights based on the 
assumption of 100% mass recovery of the polymer where the dn/dc value was unknown.  
1H NMR spectroscopic analysis was performed on a Varian Unity Plus 400 MHz spectrometer using the 
deuterated solvent as reference. 
Hydrodynamic diameters (Dh) and size distributions of the nanoparticles in aqueous solutions were 
determined by dynamic light scattering (DLS). DLS measurements were performed using a Malvern 
high performance particle sizer (HPPS) with a 3.0 mW He-Ne laser operated at 633 nm at an angle of 
173o (back scattering) and a constant temperature of 25 ± 0.1 oC. 
A HeNe laser of wavelength 632.8 nm illuminates the sample, and an avalanche photodiode (APD), 
located on a goniometer, measures the scattered intensity at a specific scattering angle θ. The accessible 
angular range is 15◦–150◦, corresponding to a q range of ∼3.8–28µm−1, encompassing the peak in the 
structure factor at q ∼ 19 µm−1 . 
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Static light scattering (SLS) measurements were performed using a commercially available laser light 
scattering spectrometer (ALV-DLS/SLS-5022F) equipped with an ALV 6010 multi-tau correlator and 
Avalanche Photodiode Detectors. The laser source was a He-Ne laser with a power output of 22 mW 
operating at a wavelength of 632.8 nm. Samples were prepared in millipore water, filtered with 0.2 µm 
filters, at concentrations from 0.5 ~ 2 mg/mL. Samples were transferred to cylindrical glass scattering 
cells, and placed in an index matching fluid (ethanol) in a temperature control vat at 25 oC. Light 
scattered from the sample was detected at 28 angles from 15o to 150o. The data acquisition was carried 
out using the ALV-Correlator Control Software, and the accumulation times at each angle were 300 s to 
600 s, depending on concentration.  
Matrix-assisted laser desorption/ionization Time of Flight (MALDI-ToF) mass spectroscopy was 
performed on a Bruker Autoflex III Mass Spectrometer operating in positive linear mode; the analyte, 
matrix (DCTB) and cationisation agent (NaI) were dissolved in THF at concentrations of 10, 10, and 1 
mg/mL, respectively, and then mixed in a ratio of 10:1:1. Then 0.3 µL of this solution was spotted onto 
a ground steel target plate and the solvent was allowed to evaporate prior to analysis. FlexAnalysis 
(Bruker) was used to analyze the data.  
UV-vis spectrometry was performed on a Shimadzu UV-2101PC spectrometer using quartz cuvettes 
with a 1 cm path length. 
Transmission electron microscopy (TEM) samples were prepared by directly depositing a droplet of 
sample solution on copper grid coated by Formvar/Carbon film and draining excess solution by using 
filter paper after 60 s. To negatively stain the sample, a droplet of 2% (w/v) uranyl acetate solution was 
placed on the copper grid for 30 s before being drained with filter paper. The grid was then dried in the 
air for another 20 min. The images were taken using a FEI Tecnai TF20 transmission electron 
microscope operated at 100 kV. Images were acquired digitally with a Gatan US1000 2k × 2k CCD 
Camera. 
Cryo-transmission electron microscopy (Cryo-TEM) samples were prepared and observed as described 
by Eisenberg.5 Frozen hydrated grids of polymer samples were observed on a FEI Tecnai F30 
microscope operating at 200kV. Samples were applied to glow-discharged Quantifoil grids (Quantifoil 
Micro Tools GmbH), blotted and frozen in liquid ethane slush and stored in liquid nitrogen until loaded 
onto a cryogenic sample holder (Gatan 626). Images recorded on a Gatan Ultrascan 4k × 4k Digital 
(CCD) Camera System under low dose conditions (~10 e- Å-2) at a nominal magnification of 50,000×.  
Atomic Force Microscopy (AFM) sample was prepared by depositing a droplet of sample solution on 
silicon wafer which was treated by Piranha solution. After drying in the air, it was subjected directly for 
measurement. The images were recorded in air with a JPK microscope operating in dry Tapping mode. 
The probes were commercially available silicon tips (MicroMasch) with a spring constant of 42 N/m, a 
resonance frequency of 285 kHz and a typical radius of curvature in the 10~12 nm range. Silicon wafer 
freshly treated by Piranha solution was used as sample substrate materials. 
Thermogravimetric analysis (TGA) was performed on a PerkinElmer Pyris-1 thermogravimetric 
analyzer, and the samples were heated from 70 to 700 oC at a heating rate of 10 oC/min under a 
atmosphere flow (20 mL/min). 
Synthesis of ω-oxanorbornenyl alkyne (ONB-alkyne), 1. Precursor ONB-alkyne was prepared 
from ONBAn as reported in the literature.6 1H NMR (400 MHz, CDCl3): δ (ppm) 6.55 (s, 2H, 
CHCH=CHCH), 5.31 (s, 2H, OCHCH=CHCHO), 4.24 (d, 2H, NCH2CCH), 2.90 (s, 2H, CHCON), 
2.19 (s, 1H, NCH2CCH). 13C NMR (100 MHz, CDCl3): δ (ppm) 174.3, 137.1, 81.1, 75.2, 70.6, 46.9, 
27.1. 
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Synthesis of ω-oxanorbornenyl poly(ethylene oxide) (Mn = 2000) macromonomer (ONB-
PEG2K, 2) via “click” coupling reaction between ONB-alkyne, 1 and PEG2K-N3. The general 
procedure was followed as reported in the literature.3,6 The 1H NMR and MALDI-TOF mass 
characterization of the final product was utilized to confirm the integrity of polymerizable 
oxanorbornene functionality. 
Linear-brush type diblock copolymers of poly(ONBAn)-b-poly(ONB-PEG2K), 3, by ring-
opening metathesis polymerization (ROMP). In a typical experiment, 8 mL of distilled THF was 
degassed by three freeze-pump-thaw cycles. First monomer ONBAn (0.12 g), second monomer ONB-
PEG2K (0.162 g) and pyridine modified 2nd generation Grubbs’ catalyst (21 mg) were placed in three 
reaction vessels and evacuated by argon for 5 min. 2 mL of THF was added into each monomer flask 
and 4 mL into catalyst. After a few minutes, the catalyst solution was added into monomer solution 
under vigorously stirring. After 5 min, second monomer solution was injected rapidly into the reaction 
mixture. The reaction mixture was stirred for further 3 hours. The polymerization was terminated by the 
addition of a few droplets of ethyl vinyl ether. The polymer was then precipitated from diethyl ether 
twice to yield a grey solid powder. Yield = 100%. 
The first monomer ONBAn was easily polymerized to a nearly quantitative yield in 5 min, which 
was confirmed by the total disappearance of vinyl proton signal at δ 6.51 ppm attributed to the 
oxanorbornene monomer in 1H NMR spectrum (data not shown). The second monomer was added 
quickly into the reaction solution right after 5 min and then polymerized for 3 hrs. The conversion was 
confirmed by 1H NMR as well to make sure it was nearly 100%. After termination and purification, it 
gave light grey powder, 3: Mn (GPC) = 14,500, Mw/Mn = 1.14 for P(ONBAn)25-b-P(ONB-PEG2K)5 (the 
number in the subscript is the repeating units of monomers) and Mn (GPC) = 19,400K, Mw/Mn = 1.16 for 
P(ONBAn)50-b-P(ONB-PEG2K)5. 
Hydrolysis of diblock copolymers, 3 to yield poly(ONBA)-b-poly(ONB-PEG2K), 4. The block 
copolymer (0.31 g) was added into 15 mL 0.1 M NaOH solution. This solution was stirred for 1 hour 
until it turned to be clear. The solution was then dialyzed against distilled water for 2 days to remove 
NaOH using Spectra/Por (Spectrum Laboratories Inc.) regenerated cellulose dialysis membrane with a 
molecular weight cutoff of 2000 Da. After freeze-drying, grey viscous product, 4, was obtained for 
further self-assembly without treatment: P(ONB-diacid)25-b-P(ONB-PEG2K)5 (denoted as DP25) and 
P(ONB-diacid)50-b-P(ONB-PEG2K)5 (denoted as DP50), respectively. 
Preparation and cross-linking of polymer vesicles from poly(ONB-diacid)m-b-poly(ONB-
PEG2K)n, 4. The diblock copolymer, 4 (Mn = 14,500, 30 mg, 2.07 × 10-6 mol) was dissolved in 10 mL 
milli-Q water at a concentration of 3 mg/mL. pH value of the solution was adjusted to be ~12 (measured 
by pH meter) by adding 2M NaOH solution (~50 µL). Sample was then filtered through a PTFE filter 
(pore size 0.45 µm). Subsequently, 2 M HCl solution was added dropwise into the solution until the pH 
value to 4. The particle size was confirmed by dynamic light scattering (DLS). 
A solution of cross-linker PETMP (7 mg, 1.43 × 10-5 mol) and photo initiator DMPA (1.6 mg, 6.24 × 
10-6 mol) was prepared in 2 mL distilled THF. An aliquot of 200 µL solution was withdrawn and added 
slowly into above polymer micellar solution with stirring. The mixture was kept stirring for extra 4 
hours under dark and then radiated under 365 nm UV lamp for overnight. The final solution was 
dialyzed again milli-Q water for 2 days to remove all impurities including excess THF and some salts 
using regenerated cellulose dialysis membrane with a molecular weight cutoff of 8000 Da. At the 
meantime, pH value was increased to 7. Morphological observation of the cross-linked polymer micellar 
suspension was performed by DLS, SLS, TEM and AFM. 
Drug conjugation of cis-platinum to cross-linked polymer vesicles. The conjugation of cis-
platinum to the polymer vesicles was followed by modified procedure as reported in the literatures.7,8 
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The complex can be obtained either by adding cis-dichlorodiamine-platinum(II) (CDDP), one of 
popular forms of cis-platinum drugs,  directly to the aqueous solution of cross-linked polymer vesicles, 
or via the reaction with cis-diaminediaqua platinum(II) complex obtained by hydrolysis of CDDP by 
adding AgNO3. The later has much higher rate of complexation than the former. 
 CDDP (10 mg) was suspended in 10 mL distilled water and mixed with silver nitrate 
([AgNO3]/[CDDP] = 1.955) to form the aqueous complex. The solution was stirred in the dark at room 
temperature for 4 h. White precipitate of silver chloride was observed indicative of the proceeding 
reaction. The mixture was then centrifuged at 4400 rpm for 1 hour to remove the AgCl precipitates and 
the supernatant was purified by passing through a 0.22 µm filter. Polymers vesicles (38 mg, dissolved in 
3 mL of NaOH solution (1 mg/mL) and stirred for half an hour) were added to the above CDDP 
aqueous solution and left to react in a water bath at 37 oC for 12 h with gentle shaking resulting in 
polymer-platinum conjugates. The resultant conjugates were purified by dialysis against distilled water 
using regenerated cellulose dialysis membrane with a molecular weight cut-off of 8000 Da, followed by 
freeze-drying, yielding light brown powder. 
The platinum conjugation efficiency to polymer nanoparticles was defined as followed and determined 
by TGA: 
! = ! !!",!"#!!",!!!" !×100% = !!" !!"!!"!!"#$ !!"!!"#$ !×100% 
where mPt, exp: the molar amount of Pt determined by experimental data; mPt, theo: the theoretical molar 
amount of Pt in 100% conversion (assume that one Pt molecule forms complex with one di-acid 
repeating unit); WPt: weight percent of Pt measured by TGA; MPt: molecular weight of Pt; Wdi-acid: 
weight percent of di-acid repeat unit calculated by TGA data; Mdi-acid: molecular weight of di-acid 
repeating unit. 
The platinum loading content to polymer nanoparticles was defined as: Loading!content = ! amount!of!loaded!CDDP!amount!of!polymer!carrier+ amount!of!loaded!CDDP×100% 
Release of platinum drug from polymer-platinum conjugates. The release of the platinum drug 
from the polymer vesicles can be triggered by the presence of chloride ions, which will lead to ligand 
exchange of the platinum complex from carboxylato ligand to chloride ligand. The drug is then cleaved 
from the polymer vesicles as CDDP. This process is favoured in the presence of high amounts of 
chlorides, but not in chloride free buffers. Buffers such as the chloride containing phosphate buffered 
saline (PBS) or simple saline (0.9%) can force the release of CDDP. The in vitro release of the CDDP 
from polymer vesicle solution was performed by a dialysis method. The polymer-platinum conjugate 
(cis-platinum loaded CPV25) at a concentration of 5 mg/mL was added to dialysis tubing and dialyzed 
at 37 oC against 0.9% saline solution of pH 7.4, which mimics the environment in plasma. At certain 
time intervals, the release medium was sampled and analysed by means of o-phenylenediamine 
colorimetric assay (o-PDA). 
Polymeric platinum conjugates (10 mg) were dissolved in 2 mL saline solution 0.9% NaCl (pH 7.4) 
and dialyzed (cellulose tubing with molecular weight cut-off of approximately 8000 Da) against saline 
0.9% solution (1 L) at 37 oC. Aliquots of 1 mL were taken at regular time intervals from the dialysate 
over 143.5 h. The amount of released Pt was determined using the o-phenylenediamine colorimetric 
assay (o-PDA) carried out according to a previously published method.8-10 
Samples with an unknown Pt content were added to 1 mL of o-PDA solution in N,N’-
dimethylformamide (DMF) 2 mg/mL) and heated for 10 min at 100 oC. The amount of Pt present in the 
sample was determined by measuring the absorbance at 703 nm using CDDP as a standard curve. The 
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concentration of Pt released from the conjugate was expressed as a ratio of the amount platinum in the 
releasing solution and that in the initial sample. The percentage of Pt released was calculated using the 
equation below. %!CDDP!released = !!!"!#$ ! ×! + !!  
where Vtotal(t): remaining volume in the releasing container at time t, mL; C: concentration of platinum 
determined from UVvis measurements, µg/mL; Y: the amount of platinum that has already been 
collected, µg; Z: total amount of platinum at t = 0 present in the dialysis bag, µg. 
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Synthesis and Characterization of Diblock Copolymer 
 
Scheme S1 Synthesis of ω-oxanorbornenyl poly(ethylene oxide) (Mn = 2000) macromonomer (ONB-
PEG2K), 2. 
 
 
Fig. S1 1H NMR spectrum of macromonomer ONB-PEG2K, 2. 
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Fig. S2 MALDI-TOF mass spectrum of macromonomer ONB-PEG2K, 2. 
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Fig. S3 GPC traces of diblock copolymers P(ONBAn)m-b-P(ONB-PEG2K)n, 3. 
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Fig. S4 Typical 1H NMR spectrum of diblock copolymers P(ONBAn)m-b-P(ONB-PEG2K)n, 3.  
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Dynamic and Static Light Scattering (DLS & SLS) Measurements 
 
Fig. S5 Hydrodynamic particle size distributions of linear-brush diblock copolymer P(ONB-diacid)25-b-
P(ONB-PEG2K)5 (DP25) at different pH. The concentration was 3 mg/mL. The Dh values were 
measured 10 min after the solutions preparation. 
 
Scheme S2 The proposed chemical structures of interpolymer complexation (IPC) between 
poly(carboxylic acid) and polyoxanorbornene ether backbone, PEG brush or both for the self-assembly 
of block copolymer P(ONB-diacid)m-b-P(ONB-PEG2K)n ,4, in acidic solutions. As shown in the 
scheme, the polymer vesicle structure would not be destroyed at all even if all of the protonated acid 
functionalities form complex only with PEG brush, because the amounts of ether groups in PEG brush 
are far more than protonated acid functionalities in the used pH range. 
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Fig. S6 Particle sizes and size distributions of self-assembled diblock copolymer P(ONB-diacid)50-b-
P(ONB-PEG2K)5 (DP50) at different pH conditions after cross-linking. 
 
SLS Measurements 
For small sized particles (qR < 1, where q = scattering vector and R is the aggregate radius), the 
radius of gyration Rg can be calculated from a Zimm plot or Guinier approximation. When the ratio of 
Rg/Rh is close to unity it indicates that a hollow particle (vesicle) is present, as opposed to a value of 
0.77, which corresponds to a solid sphere or micelle.11,12 However, in this case the qR values are greater 
than 1 and Rg cannot be easily measured using this technique. 
Instead the intensity as a function of scattering angle of incident light was measured and fitted 
with mathematical models for both spherical hollow spheres (vesicles) and solid spheres (micelles) in 
order to confirm whether or not the self-assemblies truly are vesicles, and determine particle sizes and 
shell thickness.13 The scattering factor, P(q), for hollow spheres with a shell of thickness t can be 
expressed as follows:  P ! = 3!!! − !!! !× !!! !! !!!!!! − !!! !! !!!!!! ! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!(S1) 
Where R is the average radius, R0 = R + t / 2 is the outer radius, Ri = R – t / 2 is the inner radius and j1(x) is the 
first-order spherical Bessel function given by:                                     !! ! = sin !!! − cos !! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!(S2) 
As a comparison, a solid sphere model (as would be the case for a micelle) is also used: P ! = 43π!!× 3 sin !" − !" cos !"!" ! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!(S3) 
In a polydisperse suspension of particles, the total scattering intensity as a function of angle will be 
given by: ! ! = !!! !,! ! ! !"!!  
where G(R) is the particle size distribution. Both log-normal and Schultz distributions were tried, each 
characterized by a mean radius, R, and a polydispersity, σ. The details of the analysis and fitting 
methods are described in previous publications.14,15  
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Fig. S7 Scattered intensity correlation as a function of the angle of incident light for the cross-linked 
polymer vesicle from P(ONB-diacid)25-b-P(ONB-PEG2K)5 (CPV25). The lines correspond to the fits 
generated using the hollow sphere (vesicle) (red line) and solid sphere (micelle) model (green line). 
Particle size D =  132 nm; Shell thickness t = 27 nm, log Normal distribution with σ = 43%. No good fit 
could be obtained with the solid sphere model: for comparison, the calculated data for a solid sphere 
with the same parameters is shown (green line). 
 
 
 
Fig. S8 Scattered intensity correlation as a function of the angle of incident light for the cross-linked 
polymer vesicle from P(ONB-diacid)50-b-P(ONB-PEG2K)5 (CPV50). The lines correspond to the fits 
generated using the hollow sphere (vesicle) (red line) and solid sphere (micelle) model (green line). 
Particle size D =  188 nm; Shell thickness t = 37 nm, Schultz distribution with σ = 31%. No good fit 
could be obtained with the solid sphere model: for comparison, the calculated data for a solid sphere 
with the same parameters is shown (green line). 
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The two different samples were fitted with both log-normal distributions and Schultz distributions, 
assuming both solid sphere (micelle) and hollow sphere (vesicle) models, and the best fit results are 
shown in the figures above (Fig. S7 & S8). The size distributions of the vesicle fits are shown in Fig. S9, 
which shows that CPV25 has a smaller average size, but a larger polydispersity (distribution width) than 
CPV50. The large polydispersities are consistent with the results from Cryo-TEM 
 
 
Fig. S9 Particle size distributions for samples of cross-linked polymer vesicles from diblock copolymer 
P(ONB-diacid)25-b-P(ONB-PEG2K)5 (CPV25) (blue line) and P(ONB-diacid)50-b-P(ONB-PEG2K)5 
(CPV50) (red line). It is worthy to note that CPV25 has a smaller average size, but a wider particle 
distribution than CPV50. 
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Transmission Electron Microscopy (TEM) and Cryo-TEM Measurements 
 
Fig. S10 TEM images with negative staining for the dried sample of cross-linked polymer vesicle from 
P(ONB-diacid)25-b-P(ONB-PEG2K)5 (CPV25). 
 
Fig. S11 Cryo-TEM images for the sample of cross-linked polymer vesicle from P(ONB-diacid)25-b-
P(ONB-PEG2K)5 (CPV25) with positive staining after cis-platinum loading. 
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Fig. S12 Atomic Force Microscopy (AFM) image for the sample of cross-linked polymer vesicle 
from P(ONB-diacid)25-b-P(ONB-PEG2K)5 (CPV25). The different thickness of two particles (44 nm 
and 25 nm) as indicated was originated from two distinguished particle shapes: fully enclosed (doubled 
shell thickness) and partially enclosed vesicles (singled shell thickness). 
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Cis-Platinum Drug Loading and Drug Release 
 
Fig. S13 TGA traces for CDDP (black), cross-linked polymer vesicle from P(ONB-diacid)25-b-P(ONB-
PEG2K)5 (CPV25, red) and polymer-platinum conjugate (blue, drug loaded polymer vesicles). 
Calculation of drug conjugation efficiency based on TGA data: ! = ! !!",!"#!!",!!!" !×100% = !!" !!"!!"!!"#$ !!"!!"#$ !×100% 
%100
164
100004100
4100
1.65
9.34%9.20%1.79
195
%9.20
×
"
#
$
%
&
'
+
×(
)
*
+
,
- ×−
=  
   = 88.4% 
 
Calculation of drug loading content based on conjugation efficiency: Loading!content = ! amount!of!loaded!CDDP!amount!of!polymer!carrier+ amount!of!loaded!CDDP×100% = ! 10!mg!×88.4%38!mg+ 10!mg×88.4!%×100%! = 18.9!% 
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Fig. S14 UV-vis spectra for the samples withdrawn at different time intervals during drug release study. 
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